Here's the live share price of Jubilant Pharmova along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Jubilant Pharmova has gained 8.96% CAGR. Over the past year, the corresponding return has been -1.35%.
Jubilant Pharmova’s current P/E of 38.70x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Bhartia Group Screener.
| Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) | 
|---|---|---|---|---|---|---|---|
| Jubilant Pharmova | -0.02 | 0.42 | -6.29 | 23.27 | -7.78 | 44.86 | 8.96 | 
| Sun Pharmaceutical Industries | 0.24 | 4.12 | -0.11 | -6.84 | -7.87 | 18.80 | 29.61 | 
| Divi's Laboratories | 0.89 | 16.39 | 0.70 | 8.95 | 12.77 | 22.60 | 16.18 | 
| Cipla | -2.73 | 1.76 | -0.88 | 0.97 | -0.82 | 9.72 | 15.36 | 
| Torrent Pharmaceuticals | 0.55 | 0.98 | -3.84 | 10.50 | 12.37 | 29.69 | 22.92 | 
| Mankind Pharma | 0.58 | 0.29 | -4.75 | 2.68 | -8.28 | 19.76 | 11.42 | 
| Dr. Reddy's Laboratories | -6.37 | -3.54 | -5.41 | 1.63 | -5.66 | 10.70 | 4.22 | 
| Zydus Lifesciences | -1.94 | -0.57 | 1.66 | 11.37 | -1.57 | 31.49 | 18.74 | 
| Lupin | 0.57 | -1.98 | 0.71 | -5.60 | -11.15 | 40.64 | 16.42 | 
| Alkem Laboratories | -0.43 | 1.14 | 9.75 | 8.86 | -4.52 | 20.51 | 15.96 | 
| Aurobindo Pharma | 1.46 | 1.28 | -3.50 | -9.17 | -21.13 | 26.93 | 7.34 | 
| Abbott India | -1.07 | -0.83 | -13.94 | -3.67 | 2.24 | 15.44 | 14.12 | 
| Glenmark Pharmaceuticals | 3.55 | -3.86 | -11.72 | 36.89 | 11.21 | 66.99 | 31.70 | 
| Laurus Labs | 4.84 | 11.23 | 10.95 | 56.36 | 97.19 | 28.74 | 24.89 | 
| Biocon | 4.97 | 8.80 | -3.61 | 18.31 | 19.25 | 11.87 | -1.35 | 
| GlaxoSmithKline Pharmaceuticals | -4.99 | -3.03 | -17.26 | -8.39 | -3.93 | 23.79 | 12.26 | 
| Anthem Biosciences | -0.35 | -7.04 | -5.45 | -1.78 | -1.78 | -0.60 | -0.36 | 
| Ipca Laboratories | 1.61 | -2.97 | -12.56 | -6.54 | -18.86 | 12.52 | 2.18 | 
| Gland Pharma | -1.40 | -3.44 | -7.41 | 36.14 | 15.84 | 2.33 | 0.99 | 
| Ajanta Pharma | 1.97 | 2.59 | -10.54 | -4.78 | -19.89 | 23.76 | 18.58 | 
Over the last one year, Jubilant Pharmova has declined 7.78% compared to peers like Sun Pharmaceutical Industries (-7.87%), Divi's Laboratories (12.77%), Cipla (-0.82%). From a 5 year perspective, Jubilant Pharmova has underperformed peers relative to Sun Pharmaceutical Industries (29.61%) and Divi's Laboratories (16.18%).
| Day | SMA | EMA | 
|---|---|---|
| 5 | 1,126.44 | 1,122.73 | 
| 10 | 1,103.62 | 1,116.49 | 
| 20 | 1,100.28 | 1,108.19 | 
| 50 | 1,088.19 | 1,102.96 | 
| 100 | 1,123.44 | 1,093.65 | 
| 200 | 1,036.6 | 1,056.43 | 
In the latest quarter, Jubilant Pharmova remained same as its previous close in promoter holding, while DII stake increased to 10.53%, FII holding fell to 16.56%, and public shareholding moved down to 24.60% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
| Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) | 
|---|---|---|---|
| 29,47,185 | 1.09 | 318.12 | |
| 7,54,950 | 4.13 | 81.49 | |
| 5,78,400 | 1.32 | 62.43 | |
| 2,44,236 | 0.54 | 26.36 | |
| 89,675 | 0.88 | 9.68 | 
* Excluding Index & Arbitrage Funds
| Date Time | Announcement | 
|---|---|
| Oct 27, 2025, 11:19 PM IST | Jubilant Pharmova - Letter To Shareholders Whose KYC Is Not Updated | 
| Oct 15, 2025, 12:41 AM IST | Jubilant Pharmova - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For T | 
| Oct 09, 2025, 1:51 AM IST | Jubilant Pharmova - Submission Of Communication Email Sent To Shareholders Whose Dividend(S) RemainsUnpaid Pursuant To "S | 
| Oct 07, 2025, 10:25 PM IST | Jubilant Pharmova - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 
| Oct 05, 2025, 5:26 AM IST | Jubilant Pharmova - Submission Of Second Communication Sent To Shareholders Relating To Notice Of Transfer Of Equity Shares T | 
Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 745.70 Cr. and Equity Capital is Rs. 15.90 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Jubilant Pharmova is ₹1,118.00 as on Oct 30, 2025.
The Jubilant Pharmova is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Jubilant Pharmova is ₹17,807.63 Cr as on Oct 30, 2025.
Today’s highest and lowest price of Jubilant Pharmova are ₹1,141.10 and ₹1,116.05.
The 52-week high/low is the highest and lowest price at which Jubilant Pharmova stock has traded in the past 52-week or nearly a year. The 52-week high of Jubilant Pharmova is ₹1,309.00 and 52-week low of Jubilant Pharmova is ₹823.70 as on Oct 30, 2025.
The Jubilant Pharmova has shown returns of -1.61% over the past day, 3.66% for the past month, -9.59% over 3 months, -1.35% over 1 year, 44.86% across 3 years, and 8.96% over 5 years.
P/E ratio of and PB ratio of Jubilant Pharmova are 38.70 and 3.00 on Oct 30, 2025. While the company gives a dividend yield of 0.45 per annum.